Indegene
NSE: INDGN · ISIN INE065X01017 · Healthcare
₹614.75−7.50 (−1.21%)
Monday 9 November, 13:16 IST. Delayed. Source: Yahoo Finance.
Price chart
₹614.75 −7.50 (−1.21%) today
The day
- Previous close
- ₹622.25
- Open
- ₹622.25
- Day high
- ₹625.00
- Day low
- ₹614.00
Listed on NSE since 13 May 2024.
Key numbers
- Market value
- ₹14,894 Cr
- P/E (trailing)
- 37.12
- EPS (trailing)
- ₹16.66
- Price to book
- 4.43
- Dividend yield
- 0.36%
- Return on equity
- 13.2%
- Debt to equity
- 0.05
- Profit margin
- 10.0%
- Beta
- 0.68
- Volume today
- 1.30 L
- Average volume
- 5.79 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹2,306.10 Cr | ₹266.10 Cr |
| FY24 | ₹2,589.60 Cr | ₹336.70 Cr |
| FY25 | ₹2,839.30 Cr | ₹406.70 Cr |
| FY26 | ₹3,510.50 Cr | ₹401.10 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹1,122 Cr | ₹112 Cr | – |
| Q1 FY27Apr–Jun 2026 | ₹1,063 Cr | ₹116 Cr | −0.2% |
| Q4 FY26Jan–Mar 2026 | ₹1,003 Cr | ₹80 Cr | −32.2% |
| Q3 FY26Oct–Dec 2025 | ₹942 Cr | ₹103 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹804 Cr | ₹0 | – |
| Q1 FY26Apr–Jun 2025 | ₹761 Cr | ₹116 Cr | – |
Source: Indegene’s results filed with NSE, consolidated (the whole group). Net profit is the share of Indegene’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹229 Cr | ₹206 Cr |
| Investments | ₹1,019 Cr | ₹1,100 Cr |
| Owed by customers | ₹1,145 Cr | ₹982 Cr |
| Cash and equivalents | ₹141 Cr | ₹301 Cr |
| Total assets | ₹4,693 Cr | ₹4,620 Cr |
| Borrowings | ₹0 | ₹0 |
| Total liabilities | ₹1,335 Cr | ₹1,482 Cr |
| Shareholders’ equity | ₹3,358 Cr | ₹3,139 Cr |
Source: Indegene’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Indegene
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, North America, and internationally. It operates through Enterprise Medical Solutions, Enterprise Commercial Solutions, and Other segments. The company provides AI-embedded commercialization services for biopharmaceutical, emerging biotech, and medical devices companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms, as well as provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Further, it engages in the professional, and scientific and technical activities. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.
- Industry
- Health Information Services
- Based in
- Bengaluru
- Employees
- 4,687
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Indegene in the last day or two.
Dividends and corporate actions
All companies- Dividend - Rs 2.25 Per Share
Dividend · ex-date 31 July 2026
- Dividend - Rs 2 Per Share
Dividend · ex-date 13 June 2025
- Annual General Meeting
Action · ex-date 29 August 2024
Source: NSE. Latest first.
Information only, not investment advice. Prices are delayed.